Mode
Text Size
Log in / Sign up
Phase 3 N=119 Randomized Single-blind Treatment

Reducing Dynamic Hyperinflation Through Breathing Retraining

Pulmonary Disease · COPD

Enrolled (actual)
119
Serious AEs
5.0%
Results posted
Feb 2015
Primary outcome: Primary: Exercise Duration (Time Walked on the Constant Workrate Treadmill Test) — 15.2; 17.6 minutes — p=0.63

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
breathing retraining (Other); exercise training (Other)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
US Department of Veterans Affairs
Primary completion
Jan 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
Exercise Duration (Time Walked on the Constant Workrate Treadmill Test)
15.2; 17.6 0.63

Summary

This study will compare the effects of exercise training and breathing retraining (using metronome tones) to exercise training only. Exercise training lasts 12 weeks.

Eligibility Criteria

Inclusion Criteria

  • 40 yr of age
  • FEV1 70%
  • FEV1/FVC < 70%
  • RV/TLC 120%
  • mean SpO2 90% at peak exercise (w/ or w/o O2)
  • Able to hear metronome sounds Lives near Hines, IL (Chicagoland area)

Exclusion Criteria

  • Respiratory infection/exacerbation within the previous four weeks
  • Exercise limiting heart disease (+ stress test or other indicators of heart disease or complaints of angina during the stress test)
  • Primary asthma
  • Congestive heart failure (New York Heart Association Class III or IV)
  • Exercise-limiting peripheral arterial disease (stops exercise due to intermittent claudication)
  • Stops exercise due to arthritic pain in the knee or hips (self-report)
  • Inability to walk on the treadmill
  • Pregnancy
  • Any unforeseen illness or disability that would preclude exercise testing or training
  • Participation in a formal exercise program within the previous 12 weeks
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01009099). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search